Christopher Paul Fox

30PUBLICATIONS
171CO-AUTHORS
Molecular targetsHaematological tumoursTumour immunologyPredictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Sep 18, 2026
A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.

|Aug 28, 2026
Blood-test monitoring strategies for patients established on immune-suppressing drugs: a mixed-methods study.

|Aug 23, 2026
The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Apr 22, 2026
Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.

|Dec 22, 2025
Phased Variant-Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study.

Joanna A Krupka, Ilias Moutsopoulos, Natasha H Cutmore

Pageof 5

Frequent Collaborators

9 joint publications

Toby A Eyre

9 joint publications

Pamela McKay

6 joint publications

Nicolás Martínez-Calle

6 joint publications

Kate Cwynarski